The comments received will be compiled in a response to comments document (RCOM), and provided to the dossier submitter and the Committee for Risk Assessment (RAC) along with the attachments submitted during the commenting phase.
If the dossier submitter is a manufacturer, importer or downstream user, confidential attachments will not be provided to them. The dossier submitter and RAC will be providing their response to the comments in the RCOM document.
Please be aware that submitting any information/comments after the consultation is not possible. Any relevant on-going studies should be mentioned during the consultation. However, please note that the CLH processes cannot be put on hold until the finalisation of these studies.
If the substance is an active ingredient in a plant protection product (PPP) or biocidal product (BP), comments submitted in this consultation may be used in the PPP/BP processes, and, comments received for the PPP/BP processes may be used in the CLH process.
By submitting any information and documents through the webform, you guarantee that you hold all necessary rights with regard to the information provided, including but not limited to copyright where applicable, and therefore that you are entitled to submit this information for the purposes listed herein and for its use by ECHA, including its committees. By submitting this information, you also agree that the submitted comments will be put on ECHA’s website on a regular basis during the consultation, and this may be subject to third party comments. Supportive information provided as non-confidential attachments are also published on ECHA’s website.
Please note that if an access to documents application according to Regulation (EC) No 1049/2001 on public access to documents is received regarding this information, ECHA will have to first assess the content of this information before defining its position. Therefore, you are invited to indicate below any reason for which disclosure of this information should be denied. Please note that ECHA can only examine reasons appearing in Article 4 of Regulation (EC) No 1049/2001 on public access to documents as valid.
Under Article 4(1) and (2) of the Access to Documents Regulation (Regulation (EC) No 1049/2001), several reasons are outlined as to why information submitted as confidential cannot be disclosed to persons requesting access to documents.
In the commenting field below, please explain your reasons why the documents submitted as confidential should not be disclosed if we receive a request for access to the documents. (A reason could be that the protection of your commercial interests, including intellectual property, would be undermined).